Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: Efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab

Robert Bissonnette, Richard G. Langley, Kim Papp, Robert Matheson, Darryl Toth, Micki Hultquist, Gregory P. Geba, Barbara White

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: Efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences